EPAS1 and glioblastoma: Specifically, HIF-2α inhibition combined with ICB promoted Th1 CD4+ T cells that can favor activation and phagocytic functions of microglia and macrophages through IFNγ, also reported for GBM in the context of CTLA-4 blockade [12].